Entourage Health Corp Stock Today
| ENTG Stock | 0.01 0.01 33.33% |
Performance13 of 100
| Odds Of DistressLess than 39
|
Entourage Health is selling for under 0.01 as of the 17th of December 2024; that is 33.33% down since the beginning of the trading day. The stock's lowest day price was 0.01. Entourage Health has about a 39 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 17th of November 2024 and ending today, the 17th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Entourage Health is entity of Canada. It is traded as Stock on V exchange. The company has 308.39 M outstanding shares of which 7 shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions. More on Entourage Health Corp
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Entourage Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Entourage Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Entourage Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive CEO | George Scorsis | ||||
| Thematic Idea | Health Management (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Entourage Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Entourage Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsEntourage Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Entourage Health's financial leverage. It provides some insight into what part of Entourage Health's total assets is financed by creditors.
| |||||
Entourage Health Corp (ENTG) is traded on TSX Venture Exchange in Canada and employs 14 people. Entourage Health is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Entourage Health's market, we take the total number of its shares issued and multiply it by Entourage Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Entourage Health Corp operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 308.39 M outstanding shares of which 7 shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions.
Entourage Health generates negative cash flow from operations
Check Entourage Health Probability Of Bankruptcy
Ownership AllocationEntourage Health holds a total of 308.39 Million outstanding shares. Entourage Health Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Entourage Ownership Details
Entourage Health Corp Risk Profiles
Although Entourage Health's alpha and beta are two of the key measurements used to evaluate Entourage Health's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 31.29 | |||
| Semi Deviation | 22.68 | |||
| Standard Deviation | 45.5 | |||
| Variance | 2070.25 |
Entourage Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Entourage Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Entourage Health Corporate Management
Elected by the shareholders, the Entourage Health's board of directors comprises two types of representatives: Entourage Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Entourage. The board's role is to monitor Entourage Health's management team and ensure that shareholders' interests are well served. Entourage Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Entourage Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pat Scanlon | Head Cultivation | Profile | |
| Joseph Mele | Chief Officer | Profile | |
| Michael Kraft | Strategic board | Profile | |
| Catherine Flaman | Senior Affairs | Profile | |
| Deborah Sikkema | Chief Officer | Profile |
Additional Tools for Entourage Stock Analysis
When running Entourage Health's price analysis, check to measure Entourage Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entourage Health is operating at the current time. Most of Entourage Health's value examination focuses on studying past and present price action to predict the probability of Entourage Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entourage Health's price. Additionally, you may evaluate how the addition of Entourage Health to your portfolios can decrease your overall portfolio volatility.